Editor’s pick: Cargo Therapeutics
Nature Biotechnology, Published online: 19 August 2024; doi:10.1038/s41587-024-02358-1Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. A rescued chimeric antigen receptor from Cargo Therapeutics for hard-to-treat lymphomas shows promise in patients while a trispecific advances toward human testing…
Read More
0
